eurocognitive function, sleep and well-being in patients with Cystic Fibrosis with mild lungdisease

Not Applicable

Suspended

• Conditions: Cystic Fibrosis; Respiratory - Other respiratory disorders / diseases; Human Genetics and Inherited Disorders - Cystic fibrosis

• Registration Number: ACTRN12616000454471
• Lead Sponsor: Royal Prince Alfred Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

CF Inclusion criteria
*FEV1 70 - 89%
*Stable lung function (see exclusion criteria)

Non CF healthy controls inclusion criteria
* Matched for age and education to CF participant

Exclusion Criteria

CF Patient Exclusion criteria
*Uncontrolled medical conditions
*Prescribed intravenous or oral antibiotics for CF exacerbation in the past 8 weeks
*Patients with Burkholderia cepacia and non tuberculous mycobacteria
*Prior lung transplant
*Not proficient in English
*Inability to provide informed consent

Non-CF control exclusion criteria:
* Uncontrolled medical conditions
*Acute medical conditions - eg. active lung infection
*Not proficient in English

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psychomotor vigilance test (PVT) - reaction time (ms)[Compare PVT results at baseline, during and after a lung exacerbation. Post exacerbation testing will occur 4 weeks post recovery. ]